| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $57.0M | +66.5% |
| SG&A Expense | $19.5M | +46.8% |
| Operating Income | -$76.5M | -61.0% |
| Income Tax | $0 | — |
| Net Income | -$73.9M | -54.5% |
| EPS (Basic) | -$1.79 | -9.1% |
| EPS (Diluted) | -$1.79 | -9.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.7M | -26.6% |
| Short-term Investments | $167.6M | -25.6% |
| Current Assets | $185.6M | -24.7% |
| Total Assets | $193.7M | -23.0% |
| Current Liabilities | $11.5M | +43.5% |
| Total Liabilities | $13.7M | +58.6% |
| Stockholders' Equity | $180.1M | -25.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.9M | -52.2% |
| Capital Expenditures | $3.0M | +24.9% |
| Investing Cash Flow | $55.7M | +157.8% |
| Financing Cash Flow | $242K | -99.8% |
| Free Cash Flow | -$63.9M | -50.6% |